ORTAL
The computed 12-month bankruptcy probability of ORTAL is 2.1% (moderate). The 2024 annual accounts show negative equity (€-46k) and a net result of €-14k. Its solvency ranks better than 8% of 213 sector peers (fiscal year 2024). The company has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €-46k |
| Net result | €-14k |
| Better than sector | 8% |
| Active | 3 yrs |
Strong profile, led by profitability.
All 5 axes are computed from data Checked has read.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Unlock the full score breakdown, per-year score history and the indicative credit limit from Kantoor S.
See plans →| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | -38.9% | 30.7% | |
| Net result | €-14k | €5k | |
| Equity | €-46k | €21k | |
| Gross operating margin | €83k | €32k | |
| Staff costs | €81k | €34k |
| Fiscal year | 2024 |
|---|---|
| Deposit | micro |
| Revenue | - |
| EBITDA | €2k |
| Net profit | €-14k |
| Cash flow | €-2k |
| Staff costs | €81k |
| Income taxes | - |
| Dividends | - |
| Total assets | €118k |
| Equity | €-46k |
| Debt | €164k |
| of which ≤ 1y | €72k |
| of which > 1y | €92k |
| Working capital | €-36k |
| Employees (FTE) | - |
| 2024 | |
|---|---|
| Current ratio | 0.50 |
| Quick ratio | 0.31 |
| Working capital ratio | -30.4% |
| Solvency | -38.9% |
| Debt / equity | -3.57 |
| Long-term debt ratio | -2.00 |
| Interest coverage | 0.55 |
| Gross margin | - |
| Net margin | - |
| ROA | -12.1% |
| ROE | 31.2% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €118k |
| Fixed assets | 21/28 | €82k |
| Tangible fixed assets | 22/27 | €82k |
| Current assets | 29/58 | €36k |
| Stocks & contracts in progress | 3 | €14k |
| Amounts receivable within one year | 40/41 | €5k |
| Cash & bank | 54/58 | €17k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €118k |
| Equity | 10/15 | €-46k |
| Contributions / capital | 10/11 | €15k |
| Accumulated profits (losses) | 14 | €-61k |
| Amounts payable | 17/49 | €164k |
| Amounts payable after one year | 17 | €92k |
| Amounts payable within one year | 42/48 | €72k |
| Trade debts payable within one year | 44 | €21k |
| Income statement | ||
| Gross operating margin | 9900 | €83k |
| Operating result | 9901 | €-10k |
| Financial charges | 65 | €4k |
| Result before taxes | 9903 | €-14k |
| Net result for the period | 9904 | €-14k |
| Result to be appropriated | 9905 | €-14k |
| NACE primary | Vervaardiging van medische en tandheelkundige instrumenten en benodigdheden(32500) |
| Legal form | Private limited company(610) |
| Incorporation | 02-05-2023 |
| Status | Active |
| Postal code | 1410 |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameFR | ORTAL |